The p53 pathway in vasculature revisited: A therapeutic target for pathological vascular remodeling?

Area of Science:

• Cardiovascular Biology
• Molecular Oncology
• Pharmacology

Background:

• Pathological vascular remodeling is a key factor in restenosis, transplant vasculopathy, and pulmonary arterial hypertension.
• Aberrant proliferation of vascular smooth muscle cells and inflammation drive vascular remodeling.
• The tumor suppressor p53 plays a role in regulating cell proliferation and inflammation.

Purpose of the Study:

• To review the relationship between p53 and pathological vascular remodeling.
• To summarize evidence supporting p53 pathway targeting for vascular disease treatment.

Main Methods:

• Literature review of experimental data on p53 and vascular remodeling.
• Analysis of studies on small-molecule p53 activators.

Main Results:

• p53 activation can inhibit vascular smooth muscle cell proliferation and inflammation.
• Small-molecule p53 activators show promise for therapeutic intervention.
• Targeting the p53 pathway is a potential novel strategy.

Conclusions:

• p53 activation counteracts pathological vascular remodeling.
• Pharmacological targeting of the p53 pathway may prevent vascular remodeling-associated diseases.
• Further research into p53-based therapies for vascular conditions is warranted.